Healius Ltd (ASX: HLS) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
Healius Ltd Chart and Price Data
Fundamentals Data provided by Morningstar.
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
Healius Ltd (ASX: HLS)
Latest News
⏸️ Investing
Here's why Sonic Healthcare Limited is the better dividend play than Primary Health Care Limited
⏸️ Investing
6 crash-proof investments with high dividend yields
⏸️ Investing
Should you buy Primary Health Care Limited?
⏸️ Investing
How these 3 stocks could boost your portfolio: SkyCity Entertainment Group Limited-Ord, Primary Health Care Limited and Abacus Property Group
⏸️ Investing
Is now the time to buy Primary Health Care Limited?
⏸️ Investing
3 growth stocks to profit from your parents
⏸️ Investing
Dividend Alert: This top stock pays a 4.1% yield with more to come
⏸️ Investing
Has Vision Eye got the eye from Primary Health Care Limited?
⏸️ Investing
These 2 healthcare stocks are odds-on winners
⏸️ Investing
3 companies hitting 52-week lows – is this the bottom?
⏸️ Investing
Primary Health Care Limited looks cheap after budget hit
⏸️ Investing
A BIG reason to be wary of these 3 health care stocks
Frequently Asked Questions
-
Yes, Healius has historically paid two fully franked shareholder dividends a year.
-
Healius has generally paid its shareholder dividends in March/April and September/October.
-
Healius Ltd listed on the ASX on 3 July 1998.
HLS ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About Healius Ltd
Healius Ltd (ASX: HLS) operates a network of pathology laboratories, diagnostic imaging centres, and day hospitals across Australia.
The company is Australia's second-largest pathology provider with around 2,000 collection sites and almost 100 pathology laboratories operating under a portfolio of brand names. The company says one in three pathology samples taken in Australia is tested in a Healius laboratory. It also operates around 150 imaging centres in public and private hospitals, medical centres, and community centres.
The company has identified its short-stay and day hospitals as a growth segment. It currently operates 15 day hospitals as well as four major IVF clinics.
